OREANDA-NEWS. Developers of the Russian vaccine against coronavirus Sputnik V and the British-Swedish company AstraZeneca have agreed to work together. This follows from the website of AstraZeneca. Sputnik V Twitter account notes that the British-Swedish company has accepted the offer of cooperation by Russian scientists.

“Combinations of different COVID-19 vaccines may be an important step in generating wider protection through a stronger immune response and better accessibility. This is why it is important to explore heterologous boosting to make immunisation programmes more flexible, by allowing physicians greater choice at the time of administering vaccines. It is expected that combining vaccines may lead to improved immune response,” a message posted by AstraZeneca reads. Both institutions announced the beginning of clinical trials to assess the safety and immunogenicity of the combined use of two vaccines.